Borderplex brand name medicine price differences

References

• Asplund, M, and Friberg, R, 2001. The law of one price in Scandinavian duty-free stores, American Economic Review 91 (2001), pp. 1072–83.
   Web of Science ®Google Scholar
• Bera, AK, and Jarque, CM, 1981. Efficient tests for normality, heteroscedasticity, and serial independence of regression residuals: Monte Carlo evidence, Economics Letters 7 (1981), pp. 313–18.
   Web of Science ®Google Scholar
• Blanco González, L, and Fullerton, TM, 2006. Borderplex menu evidence for the law of one price, Economics Letters 90 (2006), pp. 28–33.
   Web of Science ®Google Scholar
• Calvillo, JP, and Lal, L, 2003. Pilot study of a survey of US residents purchasing medications in Mexico, Clinical Therapeutics 25 (2003), pp. 561–77.
   PubMed Web of Science ®Google Scholar
• Casner, PR, and Guerra, LG, 1992. Purchasing prescription medication in Mexico without a prescription, the experience at the border, Western Journal of Medicine 156 (1992), pp. 512–6.
   PubMedGoogle Scholar
• Danzon, PM, and Chao, L, 2000a. Does price regulation drive out competition in pharmaceutical markets?, Journal of Law and Economics 43 (2000a), pp. 311–57.
   Web of Science ®Google Scholar
• Danzon, PM, and Chao, L, 2000b. Cross-national price differences for pharmaceuticals: how large, and why?, Journal of Health Economics 19 (2000b), pp. 159–95.
   PubMed Web of Science ®Google Scholar
• Danzon, PM, and Furukawa, MF, 2004. Prices and availability of pharmaceuticals: evidence from nine countries, Health Affairs Web Exclusive W3 (2004), pp. 521–36.
   Google Scholar
• Danzon, PM, and Furukawa, MF, 2006. Prices and availability of biopharmaceuticals: an international comparison, Health Affairs 25 (2006), pp. 1353–62.
   PubMed Web of Science ®Google Scholar
• Danzon, PM, and Kim, JD, 1998. International price comparisons for pharmaceuticals: measurement and policy issues, PharmacoEconomics 14 (1998), pp. 115–28.
   PubMed Web of Science ®Google Scholar
• Engel, C, and Rogers, JH, 1996. How wide is the border?, American Economic Review 86 (1996), pp. 1112–25.
   Web of Science ®Google Scholar
• Feria, AP, 2001. "Alternativas de precios en medicamentos para la población mexicana". In: Baz Díaz Lombardo, G, and Luna Kan, E, eds. Salud y Seguro Social, Chapter 5. México, DF: Cámara de Diputados; 2001.
   Google Scholar
• Frederick, J, 2007. The hedgehog vs. the elephant: winning the walgreen way, Drug Store News (2007), pp. 43–62.
   Google Scholar
• Fullerton, TM, and Coronado, R, 2001. Restaurant prices and the Mexican peso, Southern Economic Journal 68 (2001), pp. 145–55.
   Web of Science ®Google Scholar
• Fullerton, TM, and Molina, AL, 2007. "Borderplex economic outlook: 2007–2009". In: Business Report SR07-2. El Paso, TX: University of Texas at El Paso Border Region Modeling Project; 2007.
   Google Scholar
• Graham, JR, and Walker, M, 2000. Why are drug prices lower in Canada?, American Journal of Managed Care 6 (2000), pp. 745–6.
   PubMed Web of Science ®Google Scholar
• Jenkins, MA, 1997. Cities, borders, distances, non-traded goods and purchasing power parity, Oxford Bulletin of Economics and Statistics 59 (1997), pp. 203–13.
   Web of Science ®Google Scholar
• Johnson, S, 2007. Consumer markets, Global Insight US Economic Outlook (2007), pp. 29–40.
   Google Scholar
• Light, DW, and Lexchin, J, 2005. Foreign free riders and the high price of US medicines, British Medical Journal 331 (2005), pp. 958–60.
   PubMed Web of Science ®Google Scholar
• Manning, PL, 1997. Product liability and prescription drug prices in Canada and the United States, Journal of Law and Economics 40 (1997), pp. 203–43.
   Web of Science ®Google Scholar
• Mujumdar, S, and Pal, D, 2005. Do price ceilings abroad increase US drug prices?, Economics Letters 87 (2005), pp. 9–13.
   Web of Science ®Google Scholar
• OECD, 2001. Competition and Regulation Issues in the Pharmaceutical Industry. Paris, FR: Secretary General of the Organization for Economic Co-operation and Development; 2001.
   Google Scholar
• Quon, BS, Firszt, R, and Eisenberg, MJ, 2005. A comparison of brand name drug prices between Canadian-based internet pharmacies and major US drug chain pharmacies, Annals of Internal Medicine 143 (2005), pp. 397–403.
   PubMed Web of Science ®Google Scholar
• Ridley, DB, 2005. Price differentiation and transparency in the global pharmaceutical marketplace, PharmacoEconomics 23 (2005), pp. 651–8.
   PubMed Web of Science ®Google Scholar
• Skolnick, AA, 1995. Crossing ‘line on the map’ in search of hope, Journal of the American Medical Association 273 (1995), pp. 1646–8.
   Web of Science ®Google Scholar
• Soberón, G, and Urquidi, V, 1992. The case of Mexico, Technology in Society 14 (1992), pp. 131–6.
   Web of Science ®Google Scholar
• Sorenson, AT, 2000. Equilibrium price dispersion in retail markets for prescription drugs, Journal of Political Economy 108 (2000), pp. 833–50.
   Web of Science ®Google Scholar
• Stephens, MA, 1974. EDF statistics for goodness of fit and some comparisons, Journal of the American Statistical Association 69 (1974), pp. 730–7.
   Web of Science ®Google Scholar
• Vargas Hernández, JG, 2006. Mercado transfronterizo en servicios de salud, Ciudades 69 (2006), pp. 58–64.
   Google Scholar
• Wagner, JL, and McCarthy, E, 2004. International differences in drug prices, Annual Review of Public Health 25 (2004), pp. 475–95.
   PubMed Web of Science ®Google Scholar
• Wilson, JF, 2004. Cheaper drugs in foreign markets increase the focus on domestic drug prices, Annals of Internal Medicine 140 (2004), pp. 677–80.
   PubMed Web of Science ®Google Scholar